BIC Skin Creative
Skin sensitization potency assessment of Skin-Binding Dyes
- Cargill
Skin sensitization assessment of Hydrophobic Esters
- Clarins
Skin sensitization assessment of Natural Extracts
- Corteva Agriscience
The applicability of GARD® to Agrochemical Formulations
- Coty
Skin sensitization potency assessment of Fragrance Formulations
- DSM
Skin sensitization assessment of process-related impurities in polymeric materials
- dōTERRA
Skin sensitization thresholds of Essential Oils
- Essity Hygiene & Health
Skin sensitization testing of Facial Masks using GARD®
- ExxonMobil
The applicability of GARD® to UVCBs and Formulated Lubricant Products
- L’Oréal
Deriving a Point-of-Departure (PoD) from GARD® for downstream Quantitative Risk Assessment
- Lubrizol
The applicability of GARD® to Indirectly Acting Haptens, Hydrophobic Substances and UVCBs
- Lundbeck
Case study on Active Pharmaceutical Ingredients and Occupational Health Safety
- International Flavors & Fragrances (IFF)
Quantitative Risk Assessment of fragrance materials using a NGRA framework
- Johnson Matthey
The applicability of GARD® to Metals
- Merck
Respiratory assessment of the protein Subtilisin using GARD®air
- Research Institute for Fragrance Materials (RIFM)
Quantitative Risk Assessment of fragrance materials using a NGRA framework
- Sonova
Integrating NAMs into early-stage screening of novel materials for intended use in Medical Devices
- Takasago
The use of the GARD® to assess skin-sensitizing potency in developing novel Fragrance Ingredients
- Unilever
Skin Allergy Risk Assessment (SARA) Model: GARD® as a possible input
- Urgo
Supporting hypoallergenicity claims for Medical Wound Dressings using GARD®
